PMH - PRODUTOS MÉDICOS HOSPITALARES, S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PMH - PRODUTOS MÉDICOS HOSPITALARES, S.A. - overview
Established
1990
Location
-, -, Portugal
Primary Industry
Medical Devices & Equipment
About
Based in Portugal, PMH - Produtos Médicos Hospitalares, S. A. specializes in providing essential medical and hospital products, focusing on innovative solutions for healthcare providers and hospitals. Founded in 1990, PMH - Produtos Médicos Hospitalares, S.
A. operates in Portugal and specializes in medical products for healthcare settings. The company remains independent without known subsidiaries or parent companies. Specific details about founders or funding rounds are unavailable.
In January 2026, ActiveCap invested 5. 6 million euros in PMH - PRODUTOS MÉDICOS HOSPITALARES, S. A. PMH - Produtos Médicos Hospitalares, S.
A. specializes in a comprehensive range of medical and hospital products, primarily focusing on infusion systems, drainage equipment, and surgical accessories. Their core offerings include high-flow infusion systems, oncology infusers, and closed system products designed for safe drug administration. These products cater to healthcare providers and hospitals, addressing critical needs such as patient isolation, environmental disinfection, and effective management of hydrocephalus through neurosurgical devices.
PMH serves a diverse customer base that spans across various geographical markets, including Europe, Latin America, and regions in Asia, ensuring that their innovative solutions meet the evolving demands of the medical sector. The revenue structure of PMH is built on direct sales and partnerships with healthcare institutions, where transactions typically occur through established contracts and procurement agreements with hospitals and clinics. The company's flagship products, such as the Oncoflex® infusion systems and Neosegur® line of blood administration products, form the cornerstone of their sales strategy. Clients often engage in bulk purchasing agreements, which facilitate consistent and recurring revenue streams.
Given the specialized nature of their offerings, PMH's pricing strategy reflects a premium positioning, tailored to the sophisticated requirements of medical professionals and healthcare facilities. Transactions are structured to support both B2B interactions with institutional clients and direct sales of individual medical devices to end-users, ensuring a robust presence in the medical supply market. The January 2026 investment will support PMH - PRODUTOS MÉDICOS HOSPITALARES, S. A.
's growth strategy, through expansion into new geographies and investment in the automation of production processes.
Current Investors
ActiveCap
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies, Medical Devices & Equipment
Website
www.pmh.pt
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
PMH - PRODUTOS MÉDICOS HOSPITALARES, S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | PMH - PRODUTOS MÉDICOS HOSPITALARES, S.A. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.